Outpatient Surgery Magazine

Product & Services Showcase - June 2014

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://magazine.outpatientsurgery.net/i/321060

Contents of this Issue


Page 15 of 19

PRODUCT & SERVICES SHOWCASE 1 6 | A S U P P L E M E N T T O O U T PAT I E N T S U R G E R Y M A G A Z I N E | J U N E 2 014 THE ONE TRAY ® PRODUCT LINE The ONE TRAY ® product line is an FDA cleared, sealed, terminal filtered vent sterilization container that utilizes a 4-minute Pre-vac and minimum-zero dry time cycle. ONE TRAY ® 's completely unique technology is created through the patented design of the container and a proprietary filter for extremely high air flow efficiency. ONE TRAY ® provides unparalleled efficiencies to SPD/OR departments while saving facilities significant monies. For more information call (937)619-0138 , visit www.ISTSterilization.com or use the reader service card on p. 10 . BIG FOOT SUCTION ™ Big FOOT Suction ™ is the first and only "roaming" floor suction mat. Big FOOT can be moved around like your smaller floor suction devices, but it absorbs fluid like your larger mats. The combination of an efficient design at a low cost makes Big FOOT is a device you will want to trial and experience firsthand. Crafted to absorb and suck the fluid off of your floors during low-, moderate- or high-fluid cases, it can be utilized to suc- tion, dry, and absorb. Big FOOT has more applications for floor fluid waste management than any other floor suction device on the market. For your no-commitment trial, call us at (866) 879-2443 , visit www.floorsuction.com or use the reader service card on p. 10 . THIS MITOMYCIN KIT IS FDA-APPROVED FOR EYE SURGERY Mobius Therapeutics, LLC manufactures and markets Mitosol ® , (mitomycin for solution) 0.2 mg/vial, Kit for Ophthalmic Use, the only FDA-approved ophthalmic formulation of mitomycin. Mitosol ® permits room temperature storage without light shielding and features an extended shelf life. Assured sterility, potency, and dosing along with closed transfer and qualified disposal reinvents mitomycin for ophthalmology. Mobius has received notice from the Center for Medicare Services (CMS) of an Outpatient Prospective Payment System (OPPS) Payment Indicator "K2" for the code J7315 Mitosol ® (mitomycin for solution) Kit for Ophthalmic Use. This payment indicator allows payment for enti- ties billing under OPPS, including Ambulatory Surgical Centers (ASCs) and hospitals This code cannot be used to reimburse com- pounded mitomycin. For more information call (877) 393-6486 , visit www.MobiusTherapeutics.com or use the reader service card on p. 10 . SH_1406 edited1_Layout 1 5/23/14 11:23 AM Page 16

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Product & Services Showcase - June 2014